Form: S-8

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

November 21, 2023

Documents

Exhibit 107

Calculation of Filing Fee Table
 
FORM S-8
(Form Type)
 
Ocuphire Pharma, Inc.
(Exact Name of Registrant as Specified in its Charter)
 
Newly Registered Securities

   
Security
Type
  
Security Class Title
  
Fee
Calculation
Rule
  
Amount
Registered
(1)
  
Proposed
Maximum
Offering
price
Per Unit
  
Maximum
Aggregate
Offering Price
(2)
  
Fee Rate
  
Amount of
Registration
Fee
  
                                   
   
Equity
  
Common Stock,  par value $0.0001 per share, to be issued under the  Ocuphire Pharma, Inc. 2021 Inducement Plan
 
Other (2)
  
2,000,000 (3)

$2.945 (2)

   
$0.00014760
      
Total Offering Amounts
  

                 
$5,890,000
      
$869.36
  
Total Fee Offsets
  

                         
$0.00
  
Net Fee Due
  

                         
$869.36
  

(1)
Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended, (the “Securities Act”), this Registration Statement shall also cover any additional shares of Ocuphire Pharma, Inc. (the “Registrant”) common stock that become issuable under the Registrant’s 2021 Inducement Plan (the “Inducement Plan”) set forth herein by reason of any stock dividend, stock split, reclassification, recapitalization, spin-off or other similar transaction effected without receipt of consideration that increases the number of outstanding shares of the Registrant’s common stock, as applicable.
(2)
Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) and Rule 457(h) under the Securities Act. The offering price per share and aggregate offering price are based on the average of the high and low prices of the Registrant’s common stock as reported on the Nasdaq Capital Market on November 17, 2023.
(3)
Represents 2,000,000 shares reserved for grant under the Inducement Plan pursuant to a First Amendment to the Inducement Plan that was approved by the Registrant’s board of directors on October 30, 2023.